Unique Ingredient Identifier REK4960K2U is listed as a ingredient substance
| RN | 25013-16-5 |
| EC | 246-563-8 |
| NCIT | C44347 |
| RXCUI | 1362900 |
UNII REK4960K2U BUTYLATED HYDROXYANISOLE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INTRAMUSCULAR | INJECTION | 0.03 % |
| INTRAVENOUS INFUSION | SOLUTION, INJECTION | 0.003 mg |
| IV(INFUSION) | INJECTION | 0.002 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | NA |
| NASAL | SOLUTION | 0.02 % |
| ORAL | CAPSULE | 1 MG |
| ORAL | CAPSULE, GELATIN COATED | 0.07 MG |
| ORAL | CAPSULE, SOFT GELATIN | 1 MG |
| ORAL | CONCENTRATE | 0.075 MG/1ML |
| ORAL | EMULSION | NA |
| ORAL | GRANULE, FOR SUSPENSION | NA |
| ORAL | LIQUID | 0.1 MG/1ML |
| ORAL | SOLUTION | 189 ug/1mL |
| ORAL | SOLUTION | 0.19 MG/1ML |
| ORAL | SUSPENSION | 2.5 MG/5ML |
| ORAL | SYRUP | 0.5 MG/5ML |
| ORAL | TABLET | 0.86 MG |
| ORAL | TABLET, EXTENDED RELEASE | 0.5 MG |
| ORAL | TABLET, FILM COATED | 0.4 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 0.6 MG |
| RECTAL | SUPPOSITORY | 0.21 MG |
| SUBLINGUAL | FILM | 0.08 mg |
| SUBLINGUAL | TABLET | 1 MG |
| TOPICAL | CREAM | 0.0052 %W/W |
| TOPICAL | EMULSION, CREAM | 5.2 %W/W |
| TOPICAL | GEL | 0.05 %W/W |
| TOPICAL | LOTION | NA |
| TOPICAL | OINTMENT | 0.005 %W/W |
| TOPICAL | SOLUTION | NA |
| TOPICAL | SUPPOSITORY | NA |
| VAGINAL | EMULSION, CREAM | 0.03 % |
| VAGINAL | OINTMENT | 0.02 % |
| VAGINAL | SUPPOSITORY | 1 MG |